• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2004-2013 年伊朗戈勒斯坦甲状腺癌发病率的时间和地理趋势。

Temporal and Geographical Trends of Incidence of Thyroid Cancer in Golestan, Iran, 2004-2013.

机构信息

Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran.

Deputy of Public Health, Golestan University of Medical Sciences, Gorgan, Iran.

出版信息

Arch Iran Med. 2021 Jan 1;24(1):1-6. doi: 10.34172/aim.2021.01.

DOI:10.34172/aim.2021.01
PMID:33588561
Abstract

BACKGROUND

Thyroid cancer is the most common type of endocrine cancer. We aimed to determine the incidence rates of thyroid cancer across a 10-year period (2004-2013) in Golestan, Iran.

METHODS

We obtained the thyroid cancer data from Golestan Population-Based Cancer Registry (GPCR). Age-standardized incidence rates (ASR) were calculated and reported per 100000 person-years. The Joinpoint software was used to assess time trends, and average annual percent changes (AAPCs) and their corresponding 95% confidence intervals (CIs) were reported.

RESULTS

Of 326 registered patients, 83 (25.5%) were men and 243 (74.5%) were women. The mean age was 51.3 and 42.6 years for males and females, respectively. Overall, the ASR of thyroid cancer was 2.2 per 100000 person-year (AAPC = 2.76; 95% CI: -3.68 to 9.64). The test of co-incidence showed a statistically significant difference in the incidence of thyroid cancer between men (1.3) and women (3.2) (P < 0.001). According to our results, the ASR of thyroid cancer in western parts of Golestan is higher, including Gorgan and Aliabad cities.

CONCLUSION

Increasing trends in incidence rates of thyroid cancer were found in the Golestan province during the study period, especially in women. We found significantly higher rates of thyroid cancer in women. Geographical diversities were seen in incidence rates of thyroid cancer in the Golestan province. Our results may be helpful for designing further researches to investigate the epidemiological aspects of thyroid cancer in the Golestan province.

摘要

背景

甲状腺癌是最常见的内分泌系统癌症。本研究旨在确定伊朗戈勒斯坦省在 10 年间(2004-2013 年)甲状腺癌的发病率。

方法

我们从戈勒斯坦人群癌症登记处(GPCR)获得了甲状腺癌的数据。按每 10 万人年计算年龄标准化发病率(ASR),并进行报告。使用 Joinpoint 软件评估时间趋势,报告平均年变化百分比(AAPC)及其相应的 95%置信区间(CI)。

结果

在登记的 326 名患者中,83 名(25.5%)为男性,243 名(74.5%)为女性。男性和女性的平均年龄分别为 51.3 岁和 42.6 岁。总体而言,甲状腺癌的 ASR 为 2.2/10 万人年(AAPC=2.76;95%CI:-3.68 至 9.64)。共同发生率检验表明,男性(1.3)和女性(3.2)甲状腺癌发病率存在统计学差异(P<0.001)。根据我们的结果,戈勒斯坦西部地区(包括戈尔甘和阿里阿巴德市)的甲状腺癌 ASR 较高。

结论

在研究期间,戈勒斯坦省甲状腺癌的发病率呈上升趋势,尤其是在女性中。我们发现女性甲状腺癌的发病率显著较高。戈勒斯坦省甲状腺癌的发病率存在地理差异。我们的研究结果可能有助于设计进一步的研究,以调查戈勒斯坦省甲状腺癌的流行病学特征。

相似文献

1
Temporal and Geographical Trends of Incidence of Thyroid Cancer in Golestan, Iran, 2004-2013.2004-2013 年伊朗戈勒斯坦甲状腺癌发病率的时间和地理趋势。
Arch Iran Med. 2021 Jan 1;24(1):1-6. doi: 10.34172/aim.2021.01.
2
Trends in the Incidence of Stomach Cancer in Golestan Province, a High-risk Area in Northern Iran, 2004-2016.2004-2016 年伊朗北部高危地区戈勒斯坦省胃癌发病率趋势。
Arch Iran Med. 2020 Jun 1;23(6):362-368. doi: 10.34172/aim.2020.28.
3
Descriptive Epidemiology of Lymphoma in Northern Iran: Results from the Golestan Registry 2004-2013.伊朗北部淋巴瘤的描述性流行病学:2004 - 2013年戈勒斯坦登记处的结果
Arch Iran Med. 2020 Mar 1;23(3):150-154.
4
Incidence Rates and Time Trends of Pancreatic Cancer in the Golestan Province, Northeastern Iran, 2006-2019.2006-2019 年伊朗东北部戈勒斯坦省胰腺癌的发病率和时间趋势。
Arch Iran Med. 2024 Sep 1;27(9):486-493. doi: 10.34172/aim.31168.
5
Incidence, Time Trends and Geographical Distribution of Leukemia and Multiple Myeloma in Golestan Province, Northern Iran, 2004-2017.伊朗北部戈勒斯坦省 2004-2017 年白血病和多发性骨髓瘤的发病率、时间趋势和地理分布。
Arch Iran Med. 2022 Jun 1;25(6):360-365. doi: 10.34172/aim.2022.59.
6
Increasing trends of lung cancer in Golestan province, Northern Iran (2004-2016).伊朗北部戈尔斯坦省肺癌发病率呈上升趋势(2004-2016 年)。
Cancer Epidemiol. 2020 Apr;65:101687. doi: 10.1016/j.canep.2020.101687. Epub 2020 Feb 19.
7
Temporal and geographical variations in colorectal cancer incidence in Northern Iran 2004-2013.2004-2013 年伊朗北部结直肠癌发病率的时间和地域变化。
Cancer Epidemiol. 2019 Apr;59:143-147. doi: 10.1016/j.canep.2019.02.003. Epub 2019 Feb 13.
8
Primary Liver Cancer in Golestan Province, Northeastern Iran: 13-Year Experience of Golestan Population-Based Cancer Registry (GPCR).伊朗东北部戈勒斯坦省原发性肝癌:戈勒斯坦人群癌症登记处(GPCR)13 年的经验。
Arch Iran Med. 2021 Oct 1;24(10):727-732. doi: 10.34172/aim.2021.107.
9
Primary Biliary Tract Cancers in Golestan, Iran: 13-Year Experience of Golestan Population-Based Cancer Registry.伊朗戈勒斯坦原发性胆管癌:戈勒斯坦人群癌症登记处 13 年经验。
Arch Iran Med. 2023 Sep 1;26(9):504-509. doi: 10.34172/aim.2023.76.
10
Epidemiology of Head and Neck Cancers in Northern Iran: A 10-Year Trend Study From Golestan Province.伊朗北部头颈癌的流行病学:来自戈勒斯坦省的一项10年趋势研究。
Arch Iran Med. 2018 Sep 1;21(9):406-411.

引用本文的文献

1
Continued rise in the incidence of thyroid cancer in Iran: true increase or overdiagnosis?伊朗甲状腺癌发病率持续上升:是真正的增加还是过度诊断?
J Diabetes Metab Disord. 2025 Feb 18;24(1):68. doi: 10.1007/s40200-025-01581-0. eCollection 2025 Jun.
2
Performance of European Thyroid Imaging Reporting and Data System in Stratifying Malignancy Risk of Thyroid Nodules: A Prospective Study.欧洲甲状腺影像报告和数据系统在分层甲状腺结节恶性风险中的表现:一项前瞻性研究。
J Med Ultrasound. 2022 Sep 22;31(2):127-132. doi: 10.4103/jmu.jmu_19_22. eCollection 2023 Apr-Jun.